Trade CAI stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Caris Life Sciences, Inc. (CAI) is trading at US$29.69, down 0.03% today as of Oct 12, 16:00 EDT. The company has a market capitalisation of US$7.42B. Over the past 52 weeks, CAI has traded between US$14.19 and US$33.65. On Syfe you can trade CAI with $0 commission and add it to your watchlist.
| Previous close | US$29.70 |
|---|---|
| Market cap | US$7.42B |
| P/E ratio | 99.53 |
| 52-week range | US$14.19 – US$33.65 |
| Volume | 4.61M |
| Exchange | US |
Caris Life Sciences, Inc.
Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX.
Year: 2025
UBS Initiates Coverage on Caris Life Sciences With Neutral Rating, $28 Price Target
Sep 9, 12:23 PM · MT Newswires
-- Earnings Flash (CAI) Caris Life Sciences, Inc. Reports Q2 Revenue $263.7M, vs. FactSet Est of $238.1M
Aug 5, 8:21 PM · MT Newswires
BofA Adjusts Price Target on Caris Life Sciences to $23 From $28
Jul 13, 3:36 PM · MT Newswires
Caris Life Sciences, Inc. (CAI) stock is trading at US$29.69, -0.03% from the previous close of US$29.70.
The market cap for Caris Life Sciences, Inc. (CAI) stock is approximately US$7.42B.
The price-to-earnings ratio for Caris Life Sciences, Inc. (CAI) is 99.53, based on the latest reported earnings.
The 52-week high for Caris Life Sciences, Inc. (CAI) stock is US$33.65.
The 52-week low for Caris Life Sciences, Inc. (CAI) stock is US$14.19.
Caris Life Sciences, Inc. (CAI) does not currently pay a dividend.
Stay on top of CAI
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
